We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KREF
1251
KKR Real Estate Finance Trust
KREF
$491M
| $14.7K | ﹤0.01% |
1,204
+740
| +159% | +$8.33K |
|
1252
Webster Financial
WBS
$12.8B
| $14.6K | ﹤0.01% |
387
+128
| +49% | +$4.73K |
|
1253
Cooper Companies
COO
$14.7B
| $14.6K | ﹤0.01% |
152
+4
| +3% | +$375 |
|
1254
Acco Brands
ACCO
$400M
| $14.5K | ﹤0.01% |
2,782
+1,519
| +120% | +$7.64K |
|
1255
Enel Chile
ENIC
$6.22B
| $14.5K | ﹤0.01% |
4,344
+1,224
| +39% | +$3.61K |
|
|
FL
1256
DELISTED
Foot Locker
FL
| $14.4K | ﹤0.01% |
533
-85
| -14% | -$2.89K |
|
1257
Cleveland-Cliffs
CLF
$7.22B
| $14.4K | ﹤0.01% |
860
+486
| +130% | +$7.71K |
|
1258
Dick's Sporting Goods
DKS
$19B
| $14.4K | ﹤0.01% |
109
-12
| -10% | -$1.64K |
|
1259
MarketAxess Holdings
MKTX
$5.72B
| $14.4K | ﹤0.01% |
55
-1
| -2% | -$298 |
|
|
LNW
1260
DELISTED
Light & Wonder
LNW
| $14.3K | ﹤0.01% |
208
-23
| -10% | -$1.43K |
|
|
HCP
1261
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $14.3K | ﹤0.01% |
546
| – | – |
|
1262
Exelixis
EXEL
$13.1B
| $14.3K | ﹤0.01% |
746
+51
| +7% | +$983 |
|
1263
Compass
COMP
$9.53B
| $14.2K | ﹤0.01% |
4,071
| – | – |
|
1264
Ionis Pharmaceuticals
IONS
$9.54B
| $14.2K | ﹤0.01% |
346
+106
| +44% | +$4.07K |
|
1265
U-Haul Holding Co Series N
UHAL.B
$12.8B
| $14.1K | ﹤0.01% |
279
| – | – |
|
1266
Costamare
CMRE
$1.76B
| $14.1K | ﹤0.01% |
1,458
-756
| -34% | -$6.77K |
|
1267
Matador Resources
MTDR
$6.39B
| $14.1K | ﹤0.01% |
269
-106
| -28% | -$5.12K |
|
1268
CenterPoint Energy
CNP
$26.5B
| $14K | ﹤0.01% |
481
+13
| +3% | +$384 |
|
|
HDV
1269
iShares Core High Dividend ETF
HDV
$14.9B
| $14K | ﹤0.01% |
695
| – | – |
|
1270
Burlington
BURL
$23.4B
| $14K | ﹤0.01% |
89
+5
| +6% | +$858 |
|
1271
Algonquin Power & Utilities
AQN
$4.37B
| $14K | ﹤0.01% |
1,695
-671
| -28% | -$5.7K |
|
1272
Healthpeak Properties
DOC
$14.5B
| $13.9K | ﹤0.01% |
693
-117
| -14% | -$2.43K |
|
1273
Teleflex
TFX
$5.95B
| $13.8K | ﹤0.01% |
57
-32
| -36% | -$8.01K |
|
1274
Aramark
ARMK
$14.7B
| $13.8K | ﹤0.01% |
443
-28
| -6% | -$763 |
|
1275
Maximus
MMS
$2.94B
| $13.8K | ﹤0.01% |
163
+4
| +3% | +$329 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.